摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氟-N-[苄氧羰基]-D-苯丙氨酸 | 117467-73-9

中文名称
4-氟-N-[苄氧羰基]-D-苯丙氨酸
中文别名
苄氧羰基-4-氟-D-苯丙氨酸
英文名称
D-Z-4-F-Phe-OH
英文别名
(R)-(N-benzyloxycarbonyl)-p-fluorophenylalanine;Cbz-4-fluoro-D-phe;(2R)-3-(4-fluorophenyl)-2-(phenylmethoxycarbonylamino)propanoic acid
4-氟-N-[苄氧羰基]-D-苯丙氨酸化学式
CAS
117467-73-9
化学式
C17H16FNO4
mdl
——
分子量
317.317
InChiKey
YJSNXFAVHKHBPV-OAHLLOKOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    75.6
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:cd9127e00073c5bc98015867415bd083
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Cbz-4-fluoro-d-phe
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Cbz-4-fluoro-d-phe
CAS number: 117467-73-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C17H16FNO4
Molecular weight: 317.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氟-N-[苄氧羰基]-D-苯丙氨酸N-甲基吗啉 、 lithium aluminium tetrahydride 、 [VCl3(thf)3]N,N-二异丙基乙胺 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 25.25h, 生成 [(1R,2S,3S,4R)-4-Benzyloxycarbonylamino-1-(4-fluoro-benzyl)-5-(4-fluoro-phenyl)-2,3-bis-(2-trimethylsilanyl-ethoxymethoxy)-pentyl]-carbamic acid benzyl ester
    参考文献:
    名称:
    Preparation and Structure−Activity Relationship of Novel P1/P1‘-Substituted Cyclic Urea-Based Human Immunodeficiency Virus Type-1 Protease Inhibitors
    摘要:
    A series of novel P1/P1'-substituted cyclic urea-based HIV-1 protease inhibitors was prepared. Three different synthetic schemes were used to assemble these compounds. The first approach uses amino acid-based starting materials and was originally used to prepare DMP 323. The other two approaches use L-tartaric acid or L-mannitol as the starting material. The required four contiguous R,S,S,R centers of the cyclic urea scaffold are introduced using substrate control methodology. Each approach has specific advantages based on the desired P1/P1' substituent. Designing analogs based on the enzyme's natural substrates provided compounds with reduced activity. Attempts at exploiting hydrogen bond sites in the S1/S1' pocket, suggested by molecular modeling studies, were not fruitful. Several analogs had better binding affinity compared to our initial leads. Modulating the compound's physical properties led to a 10-fold improvement in translation resulting in better overall antiviral activity.
    DOI:
    10.1021/jm960083n
  • 作为产物:
    描述:
    DL-对氟苯丙氨酸N-甲基吗啉甲醇 、 4 A molecular sieve 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 31.0h, 生成 4-氟-N-[苄氧羰基]-D-苯丙氨酸
    参考文献:
    名称:
    通过金鸡纳生物碱催化的氨基甲酸酯保护的α-氨基酸N-羧基酸酐的动力学拆分,α-氨基酸的不对称合成。
    摘要:
    DOI:
    10.1021/ja011936q
点击查看最新优质反应信息

文献信息

  • Synthesis, in vitro biological activity, hydrolytic stability and docking of new analogs of BIM-23052 containing halogenated amino acids
    作者:Dancho Danalev、Desislava Borisova、Spaska Yaneva、Maya Georgieva、Anelia Balacheva、Tatyana Dzimbova、Ivan Iliev、Tamara Pajpanova、Zdravka Zaharieva、Ivan Givechev、Emilia Naydenova
    DOI:10.1007/s00726-020-02915-3
    日期:2020.12
    somatostatin analogs, BIM-23052 (DC-23-99) d-Phe-Phe-Phe-d-Trp-Lys-Thr-Phe-Thr-NH2, has established in vitro growth hormone inhibitory activity in nM concentrations. It is also characterized by high affinity to some somatostatin receptors which are largely distributed in the cell membranes of many tumor cells. Herein, we report the synthesis of a series of analogs of BIM-23052 containing halogenated
    一种有效的生长抑素类似物,BIM-23052 (DC-23-99) d -Phe-Phe-Phe- d -Trp-Lys-Thr-Phe-Thr-NH 2, 已在 nM 浓度下建立了体外生长激素抑制活性。它还具有对一些生长抑素受体的高亲和力的特点,这些受体主要分布在许多肿瘤细胞的细胞膜中。在此,我们报告了使用标准固相肽法 Fmoc/OtBu-strategy 合成一系列含有卤化 Phe 残基的 BIM-23052 类似物。在体外针对两种人类肿瘤细胞系(乳腺癌细胞系和肝细胞癌细胞系)以及人类非致瘤性上皮细胞系测试了这些化合物的细胞毒性作用。含有氟苯酸的类似物在 μM 范围内具有细胞毒性,因为含有 Phe (2-F) 的类似物对人肝细胞癌细胞系显示出更好的选择性。所提出的研究还表明,根据测试的细胞系,卤化 Phe 残基的积累不会增加细胞毒性。计算出的选择性指数揭示了母体化合物 BIM-23052
  • Peptide boronic acid compounds useful in anticoagulation
    申请人:Combe-Marzelle Marie Sophie
    公开号:US20050282757A1
    公开(公告)日:2005-12-22
    A method for preventing thrombosis in a setting where rapid onset and/or rapid offset of anticoagulation is required, comprising administering a compound selected from the group consisting of boronic acids which have a neutral thrombin P1 domain linked to a hydrophobic moiety capable of binding to the thrombin S2 and S3 subsites, and pharmaceutically acceptable salts, prodrugs and pharmaceutically acceptable prodrug salts of such acids.
    一种用于在需要快速发生和/或快速停止抗凝的情况下预防血栓形成的方法,包括给予从羟基烷基部位能够结合凝血酶S2和S3亚位点的中性凝血酶P1结构域的硼酸化合物中选择的化合物,以及这些酸的药学上可接受的盐、前药和药学上可接受的前药盐。
  • Moriniere, J. L.; Danree, B.; Lemoine, J., Synthetic Communications, 1988, vol. 18, # 4, p. 441 - 444
    作者:Moriniere, J. L.、Danree, B.、Lemoine, J.、Guy, A.
    DOI:——
    日期:——
  • [EN] BORONIC ACID THROMBIN INHIBITORS<br/>[FR] INHIBITEURS DE THROMBINE A BASE D'ACIDES BORONIQUES
    申请人:TRIGEN LTD
    公开号:WO2005084687A3
    公开(公告)日:2006-04-20
  • Miyazawa, Toshifumi; Iwanaga, Hitoshi; Ueji, Shinichi, Chemistry Letters, 1989, p. 2219 - 2222
    作者:Miyazawa, Toshifumi、Iwanaga, Hitoshi、Ueji, Shinichi、Yamada,Takashi、Kuwata, Shigeru
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸